Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?-Reference-Cited by-同舟云学术

Circulating tumor DNA analysis in breast cancer: Is it ready for prime-time?

Published:2019-02 Issue: Volume:73 Page:73-83
ISSN:0305-7372
Container-title:Cancer Treatment Reviews
language:en
Short-container-title:Cancer Treatment Reviews

Author:

Buono Giuseppe,Gerratana Lorenzo^ORCID,Bulfoni Michela,Provinciali Nicoletta,Basile Debora,Giuliano Mario,Corvaja Carla,Arpino Grazia,Del Mastro Lucia,De Placido Sabino,De Laurentiis Michele,Cristofanilli Massimo,Puglisi Fabio

Publisher

Elsevier BV

Reference120 articles.

1. Detection of circulating tumor DNA in early- and late-stage human malignancies;Bettegowda;Sci Transl Med,2014

2. Circulating DNA: a new diagnostic gold mine?;Ziegler;Cancer Treat Rev,2002

3. Circulating tumor cells, disease progression, and survival in metastatic breast cancer;Cristofanilli;N Engl J Med,2004

4. Perspective on circulating tumor cell clusters: why it takes a village to metastasize;Giuliano;Cancer Res,2018

5. In patients with metastatic breast cancer the identification of circulating tumor cells in epithelial-to-mesenchymal transition is associated with a poor prognosis;Bulfoni;Breast Cancer Res,2016

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ctDNA-based liquid biopsy reveals wider mutational profile with therapy resistance and metastasis susceptibility signatures in early-stage breast cancer patients;The Journal of Liquid Biopsy;2025-03

2. Cyclin-dependent kinase 4 and 6 inhibitors (CDK4/6i): Mechanisms of resistance and where to find them;The Breast;2025-02

3. ctDNA in the reading room: A guide for radiologists;European Journal of Radiology;2024-12

4. Early evaluation of circulating tumor DNA as marker of therapeutic efficacy and prognosis in breast cancer patients during primary systemic therapy;The Breast;2024-08

5. Clinical applications of next‐generation sequencing‐based ctDNA analyses in breast cancer: defining treatment targets and dynamic changes during disease progression;Molecular Oncology;2024-06-12